Titre:
  • Lenalidomide maintenance after stem-cell transplantation for multiple myeloma.
Auteur:Attal, Michel; Lauwers-Cances, Valerie; Marit, Gerald; Caillot, Denis; Moreau, Philippe; Facon, Thierry; Stoppa, Anne Marie; Hulin, Cyrille; Benboubker, Lotfi; Garderet, Laurent; Decaux, Olivier; Leyvraz, Serge; Vekemans, Marie-Christiane; Voillat, Laurent; Michallet, Mauricette; Pegourie, Brigitte; Dumontet, Charles; Roussel, Murielle; Leleu, Xavier; Mathiot, Claire; Payen, Catherine; Avet-Loiseau, Herve; Harousseau, Jean-Luc; Meuleman, Nathalie; et al.
Informations sur la publication:The New England journal of medicine, 366, 19, page (1782-1791)
Statut de publication:Publié, 2012-05
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adult
Aged
Antineoplastic Agents -- adverse effects -- therapeutic use
Disease-Free Survival
Double-Blind Method
Female
Follow-Up Studies
Humans
Kaplan-Meier Estimate
Maintenance Chemotherapy
Male
Middle Aged
Multiple Myeloma -- drug therapy -- mortality
Neoplasms, Second Primary -- epidemiology
Stem Cell Transplantation
Thalidomide -- adverse effects -- analogs & derivatives -- therapeutic use
Young Adult
Langue:Anglais
Identificateurs:urn:issn:0028-4793
info:doi/10.1056/NEJMoa1114138
info:pmid/22571202